The Ritedose Corporation, Inc. (Ritedose), the largest contract development manufacturing organization (CDMO) in the United States specializing in sterile Blow-Fill-Seal (BFS) production of unit dose ...
Yuvezzi is designed to achieve miosis 30 minutes after one drop for up to 10 hours. The eye drop is available through ...
Four eye care practitioners tell OT about how the Varilux XR seriesTM is revolutionising the personalised care they can offer ...
Viatris Inc. (Nasdaq: VTRS), a global healthcare company, today announced that four abstracts will be presented at the American Society of Cataract and Refractive Surgery (ASCRS) Annual Meeting in ...
Yuvezzi is supplied in single dose vials containing carbachol 27.5mg/mL and brimonidine tartrate 1mg/mL; one vial can be used to dose both eyes. Yuvezzi ™ (carbachol and brimonidine tartrate ...
The optical formula for IOL presbyopia correction is a familiar one. It is no different than the formula for a successful spectacle presbyopia correction — emmetropia plus the reading “add.” ...
This page lists all known medications that could potentially lead to 'Presbyopia' as a side effect. It's important to note that mild side effects are quite common with medications. The medication(s) ...
Presbyopia is a medical condition that presents with a loss of the ability to see objects in the near distance clearly. It is a gradual and progressive problem that typically manifests in the fifth ...
Credit: Orasis Pharmaceuticals. The product is expected to be available in the first half of 2024. The Food and Drug Administration (FDA) has approved Qlosi ™ (pilocarpine hydrochloride ophthalmic ...
Presbyopia is an age-related medical condition whereby a person loses the ability to see objects at near distance clearly. Everyone will develop presbyopia at some point in their lives. Even if one ...
Restaurant menus. Price tags. Caller ID. These are among the first things to become harder to read as people slide further into middle age and their eyes lose their ability to focus. What can begin as ...